Pruritus as a Patient-Reported Primary Trial End Point in Hemodialysis: Evaluation and Implications
- PMID: 32334827
- DOI: 10.1053/j.ajkd.2020.01.002
Pruritus as a Patient-Reported Primary Trial End Point in Hemodialysis: Evaluation and Implications
Comment on
-
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.N Engl J Med. 2020 Jan 16;382(3):222-232. doi: 10.1056/NEJMoa1912770. Epub 2019 Nov 8. N Engl J Med. 2020. PMID: 31702883 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
